摘要
印度1970年的《专利法》,确认了程序专利(给予某一用以制造合成药物的程序以专利),但并未确认产品专利,即对于食品、药品的物质不授予专利,仅对制造方法授予专利。这鼓励了印度制药企业大量仿制药品替代进口,制药业成为印度最具优势的产业之一。1995年印度加入WTO之后,三次修改1970年的《专利法》,以便使其专利制度与国际标准接轨,这对印度的制药业产生了重大的影响。
Since the 1970s, Indian government has implemented a series of measures aimed at promoting the indigenous pharmaceutical industry. Among them is patents' relevance to only the techniques of production rather than to drug materials, which spurred the native pharmaceutical sectors to process many kinds of medication based on the acquired formulas in order to achieve import substitute. Acceding to WTO after 1995, however, India has to adapt to the global standards of patent protection by modifying the previous rules of patent. This has again created substantial impacts on the sector in different ways.
出处
《南亚研究季刊》
2005年第2期30-34,共5页
South Asian Studies Quarterly
基金
2004年度国家社会科学基金项目"南亚次大陆经济发展与区域安全"(04CGJ003)系列论文
作者简介
邓常春,四川大学经济学院外贸系讲师;邮政编码：610064.
